Daniel Zhou
Private Equity Investor bei OrbiMed Advisors Private Equity
Ursprung des Netzwerks ersten Grades von Daniel Zhou
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Renmin University of China
680
| College/University | Other Consumer Services | 680 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.
89
| Subsidiary | Investment Managers | 89 |
WI Harper Group, Inc.
 WI Harper Group, Inc. Investment ManagersFinance WI Harper Group, Inc. (WI Harper) is a venture capital firm founded in 1993 by Peter Liu. The firm is headquartered in San Francisco, California with additional offices in Beijing and Taipei.
3
| Private Company | Investment Managers | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Daniel Zhou
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Chief Executive Officer Founder Portfolio Manager-Equities Analyst-Equity Private Equity Investor Portfolio Manager-Equities Analyst-Equity Portfolio Manager-Fixed Income Trading-Equity Portfolio Manager-Equities | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Private Equity Analyst | |
| GELESIS INC | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| 3SBIO INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Graduate Degree Graduate Degree | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| Emory University | College/University | Undergraduate Degree Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Graduate Degree Doctorate Degree | |
| New York University | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| University College Dublin | College/University | Undergraduate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Undergraduate Degree | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| FORTRESS INVESTMENT GROUP LLC | Investment Managers | Corporate Officer/Principal Chief Executive Officer | |
| SCISPARC LTD. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Keystone Heart Ltd.
 Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| XTANT MEDICAL HOLDINGS, INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ENTERO HEALTHCARE SOLUTIONS LIMITED | Medical Distributors | Director/Board Member Director/Board Member | |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services ADARx Pharmaceuticals, Inc. operates as RNA base-editing company. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member Director/Board Member | |
Charm Therapeutics Ltd.
 Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 40 |
| Israel | 5 |
| Vereinigtes Königreich | 3 |
| Cayman Islands | 2 |
| Irland | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 17 |
| Finance | 8 |
| Distribution Services | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 412 |
| Independent Dir/Board Member | 143 |
| Corporate Officer/Principal | 107 |
| Undergraduate Degree | 90 |
| Private Equity Investor | 73 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Jonathan Silverstein | 42 |
| Peter Thompson | 39 |
| Iain Dukes | 30 |
| Erez Chimovits | 30 |
| Rishi Gupta | 29 |
| Sunny Sharma | 29 |
| David Bonita | 27 |
| Guo-Liang Yu | 27 |
| Dina Chaya | 23 |
| Sheila Gujrathi | 20 |
| Klaus Veitinger | 18 |
| Michael Bart Sheffery | 16 |
| Kevin Koch | 15 |
| Ronny Ginor | 14 |
- Börse
- Insiders
- Daniel Zhou
- Unternehmensverbindungen